BELANGER; CAROLE

Patent Applications and Registrations

Patent applications and USPTO patent grants for BELANGER; CAROLE.The latest application filed is for "in vitro model of liver steatosis and fibrosing non-alcoholic steatohepatitis".

Company Profile

10.8.16

BELANGER; CAROLE - MONT-ROYAL CA
Belanger; Carole - Bondues FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
In Vitro Model Of Liver Steatosis And Fibrosing Non-alcoholic Steatohepatitis App 20220056419 - VIDAL; GUILLAUME ; et al.	2022-02-24
Pharmaceutical compositions for combination therapy Grant 11,191,749 - Hum , et al. December 7, 2	2021-12-07
Pharmaceutical Compositions For Combination Therapy App 20210275504 - FOUCART; Corinne ; et al.	2021-09-09
Methods of treatment for cholestatic and fibrotic diseases Grant 11,103,484 - Darteil , et al. August 31, 2	2021-08-31
Pharmaceutical compositions for combination therapy Grant 11,033,534 - Foucart , et al. June 15, 2	2021-06-15
Methods of treatment for cholestatic and fibrotic diseases Grant 10,905,680 - Darteil , et al. February 2, 2	2021-02-02
Methods Of Treatment For Cholestatic And Fibrotic Diseases App 20200316031 - DARTEIL; Raphael ; et al.	2020-10-08
Combination Comprising A Ppar Agonist Such As Elafibranor And An Acetyl-coa Carboxylase (acc) Inhibitor App 20200206169 - WALCZAK; ROBERT ; et al.	2020-07-02
Combination Of Elafibranor Or Derivatives Thereof With An Anti-nash, Anti-fibrotic Or Anti-cholestatic Agent App 20200121625 - WALCZAK; ROBERT ; et al.	2020-04-23
Pharmaceutical Compositions For Combination Therapy App 20200061028 - HUM; Dean ; et al.	2020-02-27
Combination Of A Ppar Agonist With A Fxr Agonist App 20200054589 - Noel; Beno t ; et al.	2020-02-20
Pharmaceutical Compositions For Combination Therapy App 20190388398 - FOUCART; Corinne ; et al.	2019-12-26
Pharmaceutical Compositions For Combination Therapy App 20190388394 - Descamps; Emeline ; et al.	2019-12-26
Methods Of Treatment For Cholestatic And Fibrotic Diseases App 20190083468 - DARTEIL; Raphael ; et al.	2019-03-21
Methods Of Treatment For Cholestatic And Fibrotic Diseases App 20190000813 - DARTEIL; Raphael ; et al.	2019-01-03
Methods of treatment for cholestatic and fibrotic diseases Grant 10,130,613 - Darteil , et al. November 20, 2	2018-11-20
Methods of treatment for cholestatic and fibrotic diseases Grant 10,130,612 - Darteil , et al. November 20, 2	2018-11-20
Methods of treatment for cholestatic and fibrotic diseases Grant 10,117,855 - Darteil , et al. November 6, 2	2018-11-06
Methods of treatment for cholestatic and fibrotic diseases Grant 10,117,856 - Darteil , et al. November 6, 2	2018-11-06
Methods Of Treatment For Cholestatic And Fibrotic Diseases App 20180092886 - DARTEIL; Raphael ; et al.	2018-04-05
Methods Of Treatment For Cholestatic And Fibrotic Diseases App 20180092885 - Darteil; Raphael ; et al.	2018-04-05
Methods Of Treatment For Cholestatic And Fibrotic Diseases App 20180092884 - Darteil; Raphael ; et al.	2018-04-05
Methods Of Treatment For Cholestatic And Fibrotic Diseases App 20180085354 - Darteil; Raphael ; et al.	2018-03-29
Methods Of Treatment For Cholestatic And Fibrotic Diseases App 20170290812 - DARTEIL; RAPHAEL ; et al.	2017-10-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.